Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
Vancouver, British Columbia--(Newsfile Corp. - May 8, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian drug manufacturer and formulator of GMP-grade MDMA and natural psilocybin, has completed its largest international export to date of MDMA capsules to Australia, supporting the treatment...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-08 7:00 AM EDT | Optimi Health Corp.
Therma Bright Inc. Provides Update on InStatin Development, Announcement of Key Strategic Advisor and Highlights Preclinical and IP Progress at InStatin
Toronto, Ontario--(Newsfile Corp. - May 8, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) ("Therma" or the "Company"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, is pleased to provide an update on the significant progress achieved at InStatin over the past...
Technology, Biotechnology, Health
2025-05-08 6:30 AM EDT | Therma Bright Inc.
Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina
Charlotte, North Carolina--(Newsfile Corp. - May 7, 2025) - Herbal Oasis ("Oasis"), the hemp derived THC-infused social seltzer brand redefining how people connect, unwind, and celebrate life, is now proud to be distributed by Carolina Premium Beverage, serving Charlotte NC and surrounding counties. Starting in May, consumers will be able...
Household / Consumer / Cosmetics, Sports, Cannabis, Health
2025-05-07 11:04 AM EDT | cbdMD
BioVaxys and Sona Nanotech Enter Research Collaboration
Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) ("Sona") announce today that they have entered into a Research Agreement ("Agreement") to collaborate on the development of...
2025-05-07 9:12 AM EDT | Sona Nanotech Inc.
Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial
Complete Pathologic Response reported in 2 patients in the Third Cohort with cutaneous squamous cell carcinoma, complementing results in prior cohort Phio to present trial results to date at a podium presentation at Society for Investigative Dermatology (SID) Annual Meeting on May 10thMarlborough, Massachusetts--(Newsfile Corp. - May 7, 2025) -...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-07 7:45 AM EDT | Phio Pharmaceuticals Corp.
NervGen Pharma Announces Results of Annual General Meeting of Shareholders
All resolutions submitted for approval were passed by shareholdersVancouver, British Columbia--(Newsfile Corp. - May 7, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, announces the results of its Annual General Meeting of Shareholders ("AGM") held on May 6, 2025.The company...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-07 7:30 AM EDT | NervGen Pharma Corp.
Beyond Medical Technologies Announces $2.5 Million Convertible Note Financing to Support Blockchain Attestation Platform
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce a non-brokered private placement for aggregate gross proceeds of $2,500,000 (the "Financing") from the sale of the following:senior secured non-interest bearing...
Technology, Pharmaceuticals, Health
2025-05-06 11:31 AM EDT | Beyond Medical Technologies Inc.
Liviniti Contact Center Earns Gold and Silver TITAN Awards
Natchitoches, Louisiana--(Newsfile Corp. - May 6, 2025) - Liviniti is proud to announce two awards that recognize the passion and dedication of its Contact Center team. The 2025 TITAN Business Awards program, with 5,000+ entries from across 60 countries, has honored the Liviniti Contact Center with a silver award for...
2025-05-06 10:20 AM EDT | Liviniti
Promino Expands Fastbreak Partnership, Activates at The Penn Relays and Key Summer Competitions
Burlington, Ontario--(Newsfile Corp. - May 6, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") is pleased to announce it is extending its successful partnership with Fastbreak AI through summer 2025. Following a surge in direct-to-consumer sales and audience engagement from February's...
Food / Beverages, Sports, Health
2025-05-06 9:57 AM EDT | Promino Nutritional Sciences, Inc.
FendX Announces Share Issuance Pursuant to IP License Agreement
Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, announces it has completed the issuance of common shares as consideration under the exclusive intellectual property...
Technology, Healthcare and Hospitals, Health
2025-05-05 8:00 PM EDT | FendX Technologies Inc.
Adia Nutrition Announces Major Share Structure Overhaul with Retirement of Approximately 15 Million Shares and Cancellation of 10 Million Share Commitment
Winter Park, Florida--(Newsfile Corp. - May 5, 2025) - Adia Nutrition, Inc. (OTC Pink: ADIA), a Winter Park, Florida-based innovator in health and wellness, is excited to announce a transformative overhaul of its share structure, including the retirement of approximately 15 million shares, reducing the outstanding common stock from 95,899,861...
Healthcare and Hospitals, Health
2025-05-05 11:02 AM EDT | Adia Nutrition Inc.
IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment
DiaSafe™, IR-MED's second product, is being developed to provide safe, real-time optical readings of biomarkers for assessment of diabetic foot ulcers The most common cause of amputation, diabetic foot ulcers can be prevented with early assessment, improving patient care and healthcare economics in a
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-05-05 8:30 AM EDT | IR-MED, Inc.
Optimi Health Obtains U.S. FDA Drug Establishment Registration
Vancouver, British Columbia--(Newsfile Corp. - May 5, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a manufacturer of GMP-certified MDMA and psilocybin, has received its U.S. FDA Establishment Identifier (FEI) number—a key regulatory step for engaging in FDA filings and compliant supply into...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-05 7:35 AM EDT | Optimi Health Corp.
Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Week(R) 2025
Dublin, Ireland--(Newsfile Corp. - May 5, 2025) - Cosmo is attending this year’s Digestive Disease Week® (DDW), held in San Diego, California from May 3-6, where its leadership team is advancing a focused agenda of strategic meetings with key...
Healthcare and Hospitals, Health
2025-05-05 12:59 AM EDT | Cosmo Pharmaceuticals N.V.
Orpyx Medical Technologies Inc. to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Calgary, Alberta--(Newsfile Corp. - May 2, 2025) - Orpyx® Medical Technologies Inc. ("Orpyx"), a leader in digital health solutions for the prevention of diabetic foot complications, today announced that Justine Jones, Senior Vice President, Commercial, will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference held at the...
Technology, Biotechnology, Investment Banking, Health
2025-05-02 10:08 AM EDT | Bloom Burton & Co. Inc.
Beyond Medical Technologies Provides Update on 2024 Annual Filings
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announces that its application for a management cease trade order ("MCTO") under National Policy 12-203 - Management Cease Trade Orders ("NP 12-203"), as previously announced...
Technology, Pharmaceuticals, Health
2025-05-02 8:30 AM EDT | Beyond Medical Technologies Inc.
Cosmo Announces EU MDR Certification for Endovision's Cerebro, expanding its real-time AI ecosystem
Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision Limited, a leading innovator in endoscopic imaging solutions, has received EU MDR certification[1] for Cerebro, a Real-Time AI-powered guide for complete Esophagogastroduodenoscopy (EGD) procedures....
Healthcare and Hospitals, Health
2025-05-02 1:08 AM EDT | Cosmo Pharmaceuticals N.V.
CIA Legacy Awards Recognize Leaders in Canadian Actuarial Profession
Ottawa, Ontario--(Newsfile Corp. - May 1, 2025) - The Canadian Institute of Actuaries (CIA) is proud to recognize the extraordinary contributions of our volunteers, whose commitment helps drive the development and success of the actuarial profession in Canada. Each year, the CIA recognizes volunteers who have reached milestones through the...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 1:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Les Prix du patrimoine de l'ICA récompensent les chefs de file de la profession actuarielle au Canada
Ottawa, Ontario--(Newsfile Corp. - 1 mai 2025) - L'Institut canadien des actuaires (ICA) est fier de souligner les contributions exceptionnelles de nos bénévoles, dont l'engagement contribue au développement et au succès de la profession actuarielle au Canada. Chaque année, l'ICA reconnaît les étapes importantes qu'ils et elles ont franchies lors...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 1:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Sona Nanotech Announces Annual Options Grants
Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") of which 1,855,0000 have been granted to Directors and Officers. Each option is...
2025-05-01 9:21 AM EDT | Sona Nanotech Inc.